London: A new life-saving antibody treatment is set to be adopted in the UK, which will benefit thousands of health service patients in hospitals vulnerable to COVID-19.
Ronapreve, which is a combination of two monoclonal antibodies, will be initially administered to those hospitalized patients who have not developed antibody response against the coronavirus, reported PTI.
Though the UK is trying it for the first time, the drug was given to former US President Donald Trump as a suite of experimental medicines when he tested COVID-positive last year.
“We have secured a brand new treatment for our most vulnerable patients in hospitals across the UK and I am thrilled to say it will be saving lives from as early as next week,” said UK Health Secretary Sajid Javid.
People who are immunocompromised, like cancer or autoimmune disease patients – who can’t build antibody response to coronavirus — will be targeted.
“Ronapreve is the first dedicated medicine developed for COVID-19 to receive marketing authorisation from the MHRA (Medicines and Healthcare products Regulatory Agency), representing a significant milestone in how the NHS is able to fight this disease,” COVID-19 Lead at Roche Products Ltd Paul McManus said.
Mumbai: The first day of the IPL mega player auction at Jeddah threw up several…
Bhubaneswar: The Odisha government has handed over the investigation into the attack on Dhramasala MLA…
Bhubaneswar: The Commissionerate of Police on Sunday issued an advisory for movement of vehicular traffic…
New York: Now that President-elect Donald Trump has tasked Elon Musk with the responsibility of co-heading…
Bhubaneswar: The Odisha government has warned its employees of stern action for sub-letting their allotted…
Mumbai: There has been a lot of talk over AR Rahman and his wife Saira…
Sundargarh: The North Odisha Development Council (NODC) would be formed in 2-3 months, said Chief…
Puri: Director General of Police (DGP) YB Khurania on Sunday reviewed the security arrangements for…